Loading page…

Report overview

The report presents 2017 as a pivotal year for the company, highlighted by BioArctic's listing on Nasdaq Stockholm and continued strategic collaborations with Eisai and AbbVie. Consolidated net sales were 140,706 kSEK, while profit for the year was 15,157 kSEK. The company ended the year with 25 employees and continued development of its Alzheimer's, Parkinson's and spinal cord injury project portfolio.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2017
Period: 1 January 2017 – 31 December 2017
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

No standards or assurance data is available for this report.

ESG & Materiality

ESG data

Indicators available in this report:

Employees
Women on the board
Women in management
Workplace fatalities

No materiality data is available for this report.

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services